Panama vs Uruguay: The number of people with susceptibility test result for rifampicin
Panama
497
in 2021
Uruguay
510
in 2021
Panama rank
79th
Uruguay rank
78th
The number of people with susceptibility test result for rifampicin over time
- Panama
- Uruguay
How they compare
Uruguay currently reports 510 against 497 in Panama, a difference of 13.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Uruguay ahead.
Panama ranks 79th and Uruguay ranks 78th of 155 countries.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Panama | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 477 | 508 | 31 | Uruguay |
| 2020s | 452.5 | 493 | 40.5 | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Panama or Uruguay?
- Uruguay, at 510 against 497 in Panama as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Panama and Uruguay?
- 13, with Uruguay ahead.
- How many years of comparable data are there for Panama and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Panama and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Panama ranks 79th and Uruguay ranks 78th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.